Kandzari DE, Weber MA, Poulos C, Cohen SA, Jones D, Pathak A. Patient preferences for interventional and pharmaceutical treatments among U.S. adults with uncontrolled hypertension. Presented at the Virtual Transcatheter Cardiovascular Therapeutics (TCT) Conference; November 4, 2021.
Mansfield CA, Poulos C, Hackshaw MD, Pugh AL, Jobanputra M. Patient preferences for first-line maintenance treatments for ovarian cancer. Presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA.
Vickers AD, Mellor P. Identifying click-throughs in choice-based conjoint studies. Presented at the Advanced Research Techniques Forum of the American Marketing Association; 2009.
Brown DS, Johnson FR, Poulos C, Messonier MM. Mother-daughter preferences & willingness to pay for HPV vaccination. Presented at the 2nd Vaccine Global Congress; December 2008.
Evans ME, Poulos C, Smith VK. Individual preferences and household choices: the potential role of dependency relationships. Presented at the 2007 ASSA Conferences; January 2007. Previously presented at the National Center for Environmental Economics Workshop: Morbidity and Mortality: How do We Value the Risk of Illness and Death?.
Johnson FR, Mladsi DM, Sparrowhawk K. Conjoint analysis: application to global pricing and reimbursement strategy. Presented at the 2005 ISPOR 8th Annual European Congress; November 7, 2005. Florence, Italy.
Lewis SA. A practical walkthrough of an epro design kickoff. Benefits and challenges with epro: outcomes and endpoints as we emerge from the long age of paper methods. Presented at the Drug Information Association conference workshop; 2005.
Lucero MA, Mladsi D, Mauskopf J. Communicating the value: developing messages for payers. Presented at the 2004 ISPOR 7th Annual European Congress; October 24, 2004. Hamburg, Germany.
Vickers AD. Adapting market simulations from choice-based conjoint analysis to pharmaceutical scenarios. Presented at the Annual Sawtooth Software Conference; 2004.
Hauber AB, Bala MV, Fehnel SE. Conducting cost-benefit and cost-utility analysis: a conjoint analysis approach. Presented at the Annual Meetings of the International Society of Pharmacoeconomics and Outcomes Research; May 2001.